• >>
  • Pharmaceuticals and Healthcare

Overactive Bladder Treatment Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 185116
April, 2018
Region : Global
Pages
CHOOSE LICENCE TYPE

COVID-19


Understand the influence of COVID-19 on the Overactive Bladder Treatment Market with our analysts monitoring the situation across the globe.






Description

Global overactive bladder treatment market, by type (idiopathic bladder overactivity and neurogenic bladder overactivity), treatment (anticholenergic drugs, beta-3 adrenergic drug, antidepressants drugs, hormones, BOTOX and others), route of administration (oral, topical, rectal, parenteral and others), end user (clinics & hospitals, ambulatory care and others) Forecast till 2025


Market Scenario

Overactive bladder is a medical condition characterized by the high frequency of urination and urge incontinence. Incidence of this condition is associated with geriatric population. Rising investment in R & D to developed innovative treatment such as gene therapy and pharmacogenomic are driving the growth of the market. Rising geriatric population increases the prevalence of overactive bladder condition resulting demand of the treatment which fuels the market.


In addition, spreading awareness of overactive bladder and its treatment by key players in the market propels the growth of market. Side effect such as constipation, dry mouth, bladder muscle contraction and mental confusion associated with the medication can restraints the growth of the overactive bladder market. Undesired systemic outcome of current treatment and lack of awareness can hamper the growth of the market. Currently at global level; young population is contributing higher share which in future turn in geriatric population this will increase the incidence of overactive bladder and resulting expansion of the market.


Segmentation

The global overactive bladder treatment market is segmented on the basis of type, treatment, route of administration and end user.

On the basis of type, the market is segmented into idiopathic bladder overactivity and neurogenic bladder overactivity.

On the basis of treatment, the market is segmented into anticholenergic drugs, beta-3 adrenergic drug, antidepressants drugs, hormones, BOTOX and others.

On the basis of route of administration, the market is segmented into oral, topical, rectal, parenteral and others.

On the basis of end user, the market is segmented into clinics & hospitals, ambulatory care and others.


Regional Analysis

Higher number of geriatric population, prevalence of overactive bladder condition, developed healthcare infrastructure and awareness of disease in North America is responsible for becoming potential market for overactive bladder treatment. On other hand presence of countries with highest geriatric population such as Japan in Asia-Pacific region can led to grow this region at higher pace.                


Key Players

The key players in the market are: Astellas Pharma, Inc., Pfizer, Inc., Allergan, Plc., Teva Pharmaceutical Industries Limited,  Mylan N.V., Medtronic plc, Endo International plc., Sanofi, Hisamitsu Pharmaceutical Co., Inc., Aurobindo Pharma Limited, Apotex Inc. and Cogentix Medical, Inc.


Segmentation

By Type:

• Idiopathic bladder overactivity 

• Neurogenic bladder overactivity


By Treatment:

• Anticholenergic Drugs

• Beta-3 Adrenergic Drug

• Antidepressants Drugs

• Hormones

• BOTOX

• Others


By Route of Administration:

• Oral

• Topical 

• Rectal

• Parenteral

• Others


By End User:

• Clinics and Hospitals

• Ambulatory Care

• Others


By Region:

• North America

• Europe

• Asia-Pacific

• LAMEA

Research Scope


The study for Global Overactive Bladder Treatment Market will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 

Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 

The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market.  

 

1. Introduction

1.1. Market Definition

1.2. Market Scope

2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions


3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 

3.6. Market Overview


4. Type Overview

4.1. Introduction

4.2. Market Size & Forecast, 2015 to 2025

4.2.1. Idiopathic bladder overactivity 

4.2.2. Neurogenic bladder overactivity

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Treatment Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. Anticholenergic Drugs

5.2.2. Beta-3 Adrenergic Drug

5.2.3. Antidepressants Drugs

5.2.4. Hormones

5.2.5. BOTOX

5.2.6. Others

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. Route of Administration

6.1. Introduction

6.2. Market Size & Forecast, 2015 to 2025

6.2.1. Oral

6.2.2. Topical 

6.2.3. Rectal

6.2.4. Parenteral

6.2.5. Others

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. End User

7.1.1. Clinics and Hospitals

7.1.2. Ambulatory Care

7.1.3. Others

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


8. Regional Overview

8.1. Introduction

8.2. Market Size & Forecast, 2015 to 2025

8.2.1. North America

8.2.1.1. U.S.

8.2.1.2. Canada

8.2.1.3. Mexico 

8.2.2. Europe

8.2.2.1. UK

8.2.2.2. Germany

8.2.2.3. France

8.2.2.4. Italy 

8.2.2.5. Spain

8.2.2.6. Rest of Europe

8.2.3. Asia-Pacific

8.2.3.1. China

8.2.3.2. India

8.2.3.3. Japan

8.2.3.4. South Korea

8.2.3.5. Rest of Asia-Pacific

8.2.4. LAMEA

8.2.4.1. Brazil

8.2.4.2. UAE

8.2.4.3. South Africa

8.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


9. Manufacturer/ Vendor Profile

9.1. The following attributes will be considered while profiling key manufacturers in this industry: 

9.1.1. Company Overview

9.1.2. Financial Synopsis

9.1.3. Recent Developments

9.1.4. R&D Investments (if any)

9.1.5. Strategy Overview (Analyst Perspective)

9.1.6. Product Portfolio

9.2. Companies Profiled

9.2.1. Astellas Pharma, Inc.  

9.2.2. Pfizer, Inc.  

9.2.3. Allergan, Plc.  

9.2.4. Teva Pharmaceutical Industries Limited 

9.2.5.  Mylan N.V. 

9.2.6. Medtronic plc 

9.2.7. Endo International plc. 

9.2.8. Sanofi 

9.2.9. Hisamitsu Pharmaceutical Co., Inc. 

9.2.10. Aurobindo Pharma Limited  

(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 


What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

Report ID :185116

Published Date :April, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

Report ID :185116

Published Date :April, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Overactive Bladder Treatment Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
  • Impact of COVID on supply/demand scenario, trade landscape & supply chain
  • How market participants are preparing/strategizing to combat the impact
  • How does the short-term & long-term scenario for Overactive Bladder Treatment Market looks like

Report ID :185116

Published Date :April, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports


  • Data Security
  • Your data is safe and secure


  • Vast Report Database
  • We have more than 2 Million reports in our database


  • Client Focused
  • Personalized updates and 24*7 support


  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support


  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie


  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports